A detailed history of Xtx Topco LTD transactions in Oric Pharmaceuticals, Inc. stock. As of the latest transaction made, Xtx Topco LTD holds 11,757 shares of ORIC stock, worth $99,934. This represents 0.01% of its overall portfolio holdings.

Number of Shares
11,757
Previous 21,638 45.67%
Holding current value
$99,934
Previous $152,000 21.05%
% of portfolio
0.01%
Previous 0.01%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$7.52 - $11.9 $74,305 - $117,583
-9,881 Reduced 45.67%
11,757 $120,000
Q2 2024

Aug 12, 2024

BUY
$6.63 - $12.93 $143,459 - $279,779
21,638 New
21,638 $152,000
Q3 2023

Nov 13, 2023

BUY
$6.05 - $9.28 $68,486 - $105,049
11,320 New
11,320 $68,000
Q3 2022

Nov 14, 2022

BUY
$3.15 - $5.24 $56,863 - $94,592
18,052 Added 88.67%
38,411 $123,000
Q2 2022

Aug 15, 2022

BUY
$2.7 - $7.07 $54,969 - $143,938
20,359 New
20,359 $91,000

Others Institutions Holding ORIC

About Oric Pharmaceuticals, Inc.


  • Ticker ORIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 39,576,700
  • Market Cap $336M
  • Description
  • ORIC Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, discovers and develops therapies for treatment of cancers in the United States. Its clinical stage product candidates include ORIC-533, an orally bioavailable small molecule inhibitor of CD73 being developed for resistance to chemotherapy- and immunotherapy-based treatment r...
More about ORIC
Track This Portfolio

Track Xtx Topco LTD Portfolio

Follow Xtx Topco LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Xtx Topco LTD, based on Form 13F filings with the SEC.

News

Stay updated on Xtx Topco LTD with notifications on news.